Regulation of Inflammatory Response Clinical Trial
Official title:
Increased SOCS 3 mRNA in Monocytes From Patients Subjected to Laparoscopic Colon Surgery
| Verified date | December 2011 |
| Source | Oslo University Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Norway: Regional Ethics Commitee |
| Study type | Observational |
Pro-inflammatory responses following laparoscopic surgery.
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | December 2011 |
| Est. primary completion date | November 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria:Colon cancer stage I-III - Exclusion Criteria:Colon cancer stage IV |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Norway | Oslo University Hospital | Oslo |
| Lead Sponsor | Collaborator |
|---|---|
| Oslo University Hospital |
Norway,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Inflammatory values for laparoscopic resection for colon cancer. | Corresponding values of SOCS3 mRNA copared to inflammatory cytokines in patients with laparoscopic resection for colon cancer. | 3 days | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04517162 -
Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients
|
Phase 1/Phase 2 |